304 related articles for article (PubMed ID: 8285611)
1. Characterization of glycopeptide-resistant enterococci from U.S. hospitals.
Clark NC; Cooksey RC; Hill BC; Swenson JM; Tenover FC
Antimicrob Agents Chemother; 1993 Nov; 37(11):2311-7. PubMed ID: 8285611
[TBL] [Abstract][Full Text] [Related]
2. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.
Patel R; Uhl JR; Kohner P; Hopkins MK; Cockerill FR
J Clin Microbiol; 1997 Mar; 35(3):703-7. PubMed ID: 9041416
[TBL] [Abstract][Full Text] [Related]
3. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
Biavasco F; Miele A; Vignaroli C; Manso E; Lupidi R; Varaldo PE
Microb Drug Resist; 1996; 2(2):231-7. PubMed ID: 9158765
[TBL] [Abstract][Full Text] [Related]
4. Glycopeptide-resistant enterococci: a decade of experience.
Woodford N
J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey.
Perlada DE; Smulian AG; Cushion MT
J Clin Microbiol; 1997 Sep; 35(9):2342-7. PubMed ID: 9276414
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals. Canadian VRE Surveillance Group.
Karlowsky JA; Zhanel GG; Hoban DJ
Diagn Microbiol Infect Dis; 1999 Sep; 35(1):1-7. PubMed ID: 10529874
[TBL] [Abstract][Full Text] [Related]
7. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
8. Characterization of glycopeptide-resistant enterococci from a Swiss hospital.
Liassine N; Frei R; Jan I; Auckenthaler R
J Clin Microbiol; 1998 Jul; 36(7):1853-8. PubMed ID: 9650924
[TBL] [Abstract][Full Text] [Related]
9. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
[TBL] [Abstract][Full Text] [Related]
10. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
Bell JM; Paton JC; Turnidge J
J Clin Microbiol; 1998 Aug; 36(8):2187-90. PubMed ID: 9665988
[TBL] [Abstract][Full Text] [Related]
11. [Molecular characterization of vancomycin-resistant enterococci isolates].
Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility studies and detection of vancomycin resistance genes in clinical isolates of enterococci in Nagasaki, Japan.
Hirakata Y; Yamaguchi T; Izumikawa K; Matsuda J; Tomono K; Kaku M; Koga H; Yamada Y; Kohno S; Kamihira S
Epidemiol Infect; 1997 Oct; 119(2):175-81. PubMed ID: 9363016
[TBL] [Abstract][Full Text] [Related]
13. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
[TBL] [Abstract][Full Text] [Related]
14. Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda.
Kateete DP; Edolu M; Kigozi E; Kisukye J; Baluku H; Mwiine FN; Najjuka CF
BMC Infect Dis; 2019 May; 19(1):486. PubMed ID: 31151413
[TBL] [Abstract][Full Text] [Related]
15. Emergence of High-level Gentamicin Resistance among
Labibzadeh M; Kaydani GA; Savari M; Ekrami A
Pol J Microbiol; 2018; 67(4):401-406. PubMed ID: 30550226
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period.
Nelson RR; McGregor KF; Brown AR; Amyes SG; Young H
J Clin Microbiol; 2000 Jun; 38(6):2112-6. PubMed ID: 10834962
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens.
Salem-Bekhit MM; Moussa IM; Muharram MM; Alanazy FK; Hefni HM
Indian J Med Microbiol; 2012; 30(1):44-51. PubMed ID: 22361760
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods.
Jorgensen JH; Crawford SA; Kelly CC; Patterson JE
Antimicrob Agents Chemother; 2003 Dec; 47(12):3760-3. PubMed ID: 14638478
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period.
Thal L; Donabedian S; Robinson-Dunn B; Chow JW; Dembry L; Clewell DB; Alshab D; Zervos MJ
J Clin Microbiol; 1998 Nov; 36(11):3303-8. PubMed ID: 9774583
[TBL] [Abstract][Full Text] [Related]
20. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital.
de Lencastre H; Brown AE; Chung M; Armstrong D; Tomasz A
Microb Drug Resist; 1999; 5(2):113-29. PubMed ID: 10432272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
